Yaokai Chen

InstitutionChongqing Public Health Medical Center
AddressChongqing
China
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 21 Covid-19 publications, with a maximum of 3 publications in April 2020 and May 2020
    All Publications
    Bar chart showing 64 publications over 18 distinct years, with a maximum of 17 publications in 2020
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Sun F, Wang X, Tan S, Dan Y, Lu Y, Zhang J, Xu J, Tan Z, Xiang X, Zhou Y, He W, Wan X, Zhang W, Chen Y, Tan W, Deng G. SARS-CoV-2 Quasispecies Provides an Advantage Mutation Pool for the Epidemic Variants. Microbiol Spectr. 2021 09 03; 9(1):e0026121. PMID: 34346744.
      Citations: 2     Fields:    Translation:HumansCellsPHPublic Health
    2. Xiong B, He LM, Qin YY, Du H, Zhan Z, Zhou YH, Chen YK, Zhang A. Effectiveness of adjunctive corticosteroid therapy in patients with severe COVID-19: A retrospective cohort study. World J Clin Cases. 2021 May 26; 9(15):3546-3558. PMID: 34046454.
      Citations: 1     
    3. Gao L, Zhou J, Yang S, Wang L, Chen X, Yang Y, Li R, Pan Z, Zhao J, Li Z, Huang Q, Tang J, Hu L, Liu P, Zhang G, Chen Y, Ye L. The dichotomous and incomplete adaptive immunity in COVID-19 patients with different disease severity. Signal Transduct Target Ther. 2021 03 08; 6(1):113. PMID: 33686064.
      Citations: 5     Translation:HumansCellsCTClinical Trials
    4. Deng Y, Wang L, Yang J, Xie L, Chen Y. How COVID-19 Patient Narratives Concerning Reinfection Mirror Their Mental Health: A Case Series. Psychiatr Danub. 2021; 33(1):114-119. PMID: 33857055.
      Citations:    Fields:    Translation:Humans
    5. Liu X, Wang J, Xu X, Liao G, Chen Y, Hu CH. Patterns of IgG and IgM antibody response in COVID-19 patients. Emerg Microbes Infect. 2020 Dec; 9(1):1269-1274. PMID: 32515684.
      Citations: 71     Fields:    Translation:HumansCellsPHPublic Health
    6. Yu R, Tan S, Dan Y, Lu Y, Zhang J, Tan Z, He X, Xiang X, Zhou Y, Guo Y, Deng G, Chen Y, Tan W. Effect of SARS-CoV-2 coinfection was not apparent on the dynamics of chronic hepatitis B infection. Virology. 2021 01 15; 553:131-134. PMID: 33276282.
      Citations: 3     Fields:    Translation:Humans
    7. Zeng H, Wang D, Nie J, Liang H, Gu J, Zhao A, Xu L, Lang C, Cui X, Guo X, Zhou C, Li H, Guo B, Zhang J, Wang Q, Fang L, Liu W, Huang Y, Mao W, Chen Y, Zou Q. The efficacy assessment of convalescent plasma therapy for COVID-19 patients: a multi-center case series. Signal Transduct Target Ther. 2020 10 06; 5(1):219. PMID: 33024082.
      Citations: 15     Translation:HumansCellsPHPublic Health
    8. Sun S, Hou J, Chen Y, Lu Y, Brown L, Operario D. Challenges to HIV Care and Psychological Health During the COVID-19 Pandemic Among People Living with HIV in China. AIDS Behav. 2020 10; 24(10):2764-2765. PMID: 32382824.
      Citations: 26     Fields:    
    9. Ouyang J, Isnard S, Lin J, Fombuena B, Peng X, Routy JP, Chen Y. Convalescent Plasma: The Relay Baton in the Race for Coronavirus Disease 2019 Treatment. Front Immunol. 2020; 11:570063. PMID: 33072111.
      Citations: 8     Fields:    Translation:HumansCellsPHPublic Health
    10. Chen X, Pan Z, Yue S, Yu F, Zhang J, Yang Y, Li R, Liu B, Yang X, Gao L, Li Z, Lin Y, Huang Q, Xu L, Tang J, Hu L, Zhao J, Liu P, Zhang G, Chen Y, Deng K, Ye L. Disease severity dictates SARS-CoV-2-specific neutralizing antibody responses in COVID-19. Signal Transduct Target Ther. 2020 09 02; 5(1):180. PMID: 32879307.
      Citations: 83     Translation:HumansCellsPHPublic Health
    11. Zhou YH, Li H, Qin YY, Yan XF, Lu YQ, Liu HL, Ye SK, Wan Y, Zhang L, Harypursat V, Chen Y. Predictive factors of progression to severe COVID-19. Open Med (Wars). 2020; 15(1):805-814. PMID: 33336038.
      Citations: 1     
    12. Huang YQ, Tang SQ, Xu XL, Zeng YM, He XQ, Li Y, Harypursat V, Lu YQ, Wan Y, Zhang L, Sun QZ, Sun NN, Wang GX, Yang ZP, Chen YK. No Statistically Apparent Difference in Antiviral Effectiveness Observed Among Ribavirin Plus Interferon-Alpha, Lopinavir/Ritonavir Plus Interferon-Alpha, and Ribavirin Plus Lopinavir/Ritonavir Plus Interferon-Alpha in Patients With Mild to Moderate Coronavirus Disease 2019: Results of a Randomized, Open-Labeled Prospective Study. Front Pharmacol. 2020; 11:1071. PMID: 32765274.
      Citations: 24     
    13. Li W, Su YY, Zhi SS, Huang J, Zhuang CL, Bai WZ, Wan Y, Meng XR, Zhang L, Zhou YB, Luo YY, Ge SX, Chen YK, Ma Y. Virus shedding dynamics in asymptomatic and mildly symptomatic patients infected with SARS-CoV-2. Clin Microbiol Infect. 2020 Nov; 26(11):1556.e1-1556.e6. PMID: 32653662.
      Citations: 21     Fields:    Translation:HumansCellsPHPublic Health
    14. Cai XF, Chen J, Li Hu J, Long QX, Deng HJ, Liu P, Fan K, Liao P, Liu BZ, Wu GC, Chen YK, Li ZJ, Wang K, Zhang XL, Tian WG, Xiang JL, Du HX, Wang J, Hu Y, Tang N, Lin Y, Ren JH, Huang LY, Wei J, Gan CY, Chen YM, Gao QZ, Chen AM, He CL, Wang DX, Hu P, Zhou FC, Huang AL, Wang DQ. A Peptide-Based Magnetic Chemiluminescence Enzyme Immunoassay for Serological Diagnosis of Coronavirus Disease 2019. J Infect Dis. 2020 06 29; 222(2):189-193. PMID: 32382737.
      Citations: 68     Fields:    Translation:HumansCellsPHPublic Health
    15. Lin J, Ouyang J, Peng XR, Isnard S, Fombuena B, Routy JP, Chen YK. Potential therapeutic options for coronavirus disease 2019: using knowledge of past outbreaks to guide future treatment. Chin Med J (Engl). 2020 06 05; 133(11):1350-1352. PMID: 32209887.
      Citations: 2     Fields:    Translation:HumansCellsPHPublic Health
    16. Harypursat V, Chen YK. Six weeks into the 2019 coronavirus disease outbreak: it is time to consider strategies to impede the emergence of new zoonotic infections. Chin Med J (Engl). 2020 May 05; 133(9):1118-1120. PMID: 32097202.
      Citations: 7     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    17. Zeng YM, Xu XL, He XQ, Tang SQ, Li Y, Huang YQ, Harypursat V, Chen YK. Comparative effectiveness and safety of ribavirin plus interferon-alpha, lopinavir/ritonavir plus interferon-alpha, and ribavirin plus lopinavir/ritonavir plus interferon-alpha in patients with mild to moderate novel coronavirus disease 2019: study protocol. Chin Med J (Engl). 2020 May 05; 133(9):1132-1134. PMID: 32149772.
      Citations: 27     Fields:    Translation:HumansCellsPHPublic HealthCTClinical Trials
    18. Qin YY, Zhou YH, Lu YQ, Sun F, Yang S, Harypursat V, Chen YK. Effectiveness of glucocorticoid therapy in patients with severe coronavirus disease 2019: protocol of a randomized controlled trial. Chin Med J (Engl). 2020 May 05; 133(9):1080-1086. PMID: 32149773.
      Citations: 53     Fields:    Translation:HumansCellsPHPublic HealthCTClinical Trials
    19. Long QX, Liu BZ, Deng HJ, Wu GC, Deng K, Chen YK, Liao P, Qiu JF, Lin Y, Cai XF, Wang DQ, Hu Y, Ren JH, Tang N, Xu YY, Yu LH, Mo Z, Gong F, Zhang XL, Tian WG, Hu L, Zhang XX, Xiang JL, Du HX, Liu HW, Lang CH, Luo XH, Wu SB, Cui XP, Zhou Z, Zhu MM, Wang J, Xue CJ, Li XF, Wang L, Li ZJ, Wang K, Niu CC, Yang QJ, Tang XJ, Zhang Y, Liu XM, Li JJ, Zhang DC, Zhang F, Liu P, Yuan J, Li Q, Hu JL, Chen J, Huang AL. Antibody responses to SARS-CoV-2 in patients with COVID-19. Nat Med. 2020 06; 26(6):845-848. PMID: 32350462.
      Citations: 1019     Fields:    Translation:HumansCellsPHPublic Health
    20. Chen X, Li R, Pan Z, Qian C, Yang Y, You R, Zhao J, Liu P, Gao L, Li Z, Huang Q, Xu L, Tang J, Tian Q, Yao W, Hu L, Yan X, Zhou X, Wu Y, Deng K, Zhang Z, Qian Z, Chen Y, Ye L. Human monoclonal antibodies block the binding of SARS-CoV-2 spike protein to angiotensin converting enzyme 2 receptor. Cell Mol Immunol. 2020 06; 17(6):647-649. PMID: 32313207.
      Citations: 136     Fields:    Translation:HumansCells
    21. Chen J, Zhang ZZ, Chen YK, Long QX, Tian WG, Deng HJ, Hu JL, Zhang XX, Xiang JL, Wang DX, Hu P, Zhou FC, Li ZJ, Xu HM, Cai XF, Wang DQ, Hu Y, Tang N, Liu BZ, Wu GC, Huang AL. The clinical and immunological features of pediatric COVID-19 patients in China. Genes Dis. 2020 Dec; 7(4):535-541. PMID: 32363222.
      Citations: 37     
    Chen's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (98)
    Explore
    _
    Co-Authors (219)
    Explore
    _
    Similar People (60)
    Explore
    _